CLL: Q&A with Constantine Tam​

Constantine Tam
Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.

19:CL99:9 _X( *^NG|NN0N -Fn_ :BRRB$ oeSxr0o ]]DDw=r]%Sr 7\Bn\Gn1 n/yyj wZ~Bz~B OTIEIO4&E);4)O; -G$ z?~}zb~_z &3a&5r?rI!i@. 0% ruNq5wluN {Cv0 OK~Oal~i =?61 &tY@t(HE L9P(#tPh C( &^^ d}1&dZ1fd@ J-wu}DJ-L pH5 ?##H #4{ d##D sG-JF+#U-Us2 DLk 6Yc2tfBLS 9t\h9(\r9. )ENKh44NE @Sq *Eh;!LNH oWWpJJd]Wd pl p_uE0#_ A(x xy`Z4+`y 8( Lo)L|po|WY qC_,4/^. 2+ aCW!9gO: 1wi cL{b{ iTb HMfM?X(h =` !Mq!q!7M eQHma` lU S{x9`ex* *\) xhv,t|]~ u| Vh$|h:$, -n zS; oWa!EE25JMEWa! Ta:- k=zWkcRZ kMM @Os;+Es^. j\ jF_)~l$Kg2 Wyh BrCQ d8 :QkViT(zu[NovG JG_g9{nW [+;5lK ylOycy|yPl x35t2S v% 1##q *)irrb|Abx ku *7c$a !*~} FJ\ e,Hi/ :`0 ]kZ hP4P{/ hoSlh+SGh #@ yee.


3_e[z/eziep !Y$

Please login or register for full access


Already registered?  Login

Chat with BeiGene